HealthTree Logo
search more_vert
close
person Sign In / Create Account
All About TECVAYLI (Teclistamab)
Posted: Mar 14, 2023
All About TECVAYLI (Teclistamab) image

HealthTree University: Know Your Therapy - All About TECVAYLI (Teclistamab)

TECVAYLI (Teclistamab) is a recently approved bispecific antibody. It works by attracting the innate immune system to come and kill the myeloma cells. In the video below you can find out and see exactly how TECVAYLI works. You can learn about the side effects and how to manage them. Additionally you can see how it is administered and the dosing schedule. Learn more about myeloma treatment at HealthTree University.

12.21    All About TECVAYLI (Teclistamab)

 

We’d like to thank our faculty who donated their time in creating these videos, including:

  • Alfred Garfall, MD

Want more?

We have over 500 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!

 

The author Cynthia Chmielewski

about the author
Cynthia Chmielewski

Cynthia (Cindy) Chmielewski is a professional educator and myeloma advocate. As a former teacher, she now teaches myeloma patients how to advocate for themselves as the Director of HealthTree University. You can follow her on Twitter @myelomateacher

Get the latest thought leadership on Multiple Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Multiple Myeloma Newsletter" for Multiple Myeloma news, life with Multiple Myeloma stories, Multiple Myeloma clinical trials, Multiple Myeloma 101 articles and events with Multiple Myeloma experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
GSK
Regeneron
Bristol Myers Squibb

Follow Us

facebook twitter